Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Leukemia

Free Subscription 10.06.2024 1 Acta Haematol 1 Am J Clin Pathol 4 Ann Hematol 1 Blood 1 Bone Marrow Transplant 1 Cancer Lett 1 Cancer Res 2 Exp Hematol 2 J Clin Oncol 1 J Pediatr Hematol Oncol 3 Leuk Lymphoma 8 Leukemia

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Haematol

1. LIU Y, Ning Y, Ghiaur G, Emadi A, et al
   Biologic and clinical characteristics of isochromosome der(17)(q10)t(15;17) in acute promyelocytic leukemia.
   Acta Haematol. 2024 May 31. doi: 10.1159/000539159.
   PubMed         Abstract available
   
   

   
   Am J Clin Pathol

2. SHI M, Morice WG
   How I diagnose large granular lymphocytic leukemia.
   Am J Clin Pathol. 2024 Jun 1:aqae064. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Hematol

3. WEI D, Liang X, Huang M, Wang C, et al
   Targeting histone deacetylase 1 (HDAC1) in the bone marrow stromal cells revers imatinib resistance by modulating IL-6 in Ph + acute lymphoblastic leukemia.
   Ann Hematol. 2024 Jun 7. doi: 10.1007/s00277-024-05830.
   PubMed         Abstract available
   
   
4. BOUCHLA A, Sotiropoulou CD, Esteb C, Loupis T, et al
   Silencing of the DNA damage repair regulator PPP1R15A sensitizes acute myeloid leukemia cells to chemotherapy.
   Ann Hematol. 2024 Jun 6. doi: 10.1007/s00277-024-05785.
   PubMed         Abstract available
   
   
5. BUDAK B, Tukel EY, Turanli B, Kiraz Y, et al
   Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities.
   Ann Hematol. 2024 Jun 5. doi: 10.1007/s00277-024-05821.
   PubMed         Abstract available
   
   
6. ZHENG B, Geng Y, Li Y, Huang H, et al
   Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through beta-catenin by acting as targets of miR-495-3p.
   Ann Hematol. 2024 Jun 3. doi: 10.1007/s00277-024-05764.
   PubMed         Abstract available
   
   

   
   Blood

7. LUSKIN MR
   Finding the perPh+ect balance in Ph+ ALL.
   Blood. 2024;143:2339-2340.
   PubMed        
   
   

   
   Bone Marrow Transplant

8. EL CHEIKH J, Ngoya M, Galimard JE, Remenyi P, et al
   Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party.
   Bone Marrow Transplant. 2024 Jun 4. doi: 10.1038/s41409-024-02300.
   PubMed         Abstract available
   
   

   
   Cancer Lett

9. YUAN J, Zhang J, Zhao B, Liu F, et al
   Single-cell transcriptomic analysis of the immune microenvironment in pediatric acute leukemia.
   Cancer Lett. 2024 Jun 4:217018. doi: 10.1016/j.canlet.2024.217018.
   PubMed         Abstract available
   
   

   
   Cancer Res

10. BERTOLI RM, Chung YJ, Difilippantonio MJ, Wokasch A, et al
    The DNA methyltransferase inhibitor 5-aza-4'-thio-2'-deoxycytidine induces C>G transversions and acute lymphoid leukemia development.
    Cancer Res. 2024 Jun 4. doi: 10.1158/0008-5472.CAN-23-2785.
    PubMed         Abstract available
    
    

    
    Exp Hematol

11. ROGERS JH, Rosen A, Reyes JM, Ketkar S, et al
    Dose-dependent effects of Dnmt3a in an inducible murine model of Kras(G12D)-driven leukemia.
    Exp Hematol. 2024 Jun 2:104248. doi: 10.1016/j.exphem.2024.104248.
    PubMed         Abstract available
    
    
12. XU JJ, Viny AD
    Chromatin organization in myelodysplastic syndrome.
    Exp Hematol. 2024;134:104216.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

13. KITTAI AS, Bond D, Huang Y, Bhat SA, et al
    Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.
    J Clin Oncol. 2024;42:2071-2079.
    PubMed         Abstract available
    
    
14. REED DR, Tulpule A, Metts J, Trucco M, et al
    Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials.
    J Clin Oncol. 2024 Jun 6:JCO2302717. doi: 10.1200/JCO.23.02717.
    PubMed         Abstract available
    
    

    
    J Pediatr Hematol Oncol

15. SHENKAR R, Kahwash SB, Rodriguez DP, Abu Arja R, et al
    Isolated Optic Nerve Relapse in a Pediatric Patient With T-Cell Lymphoblastic Leukemia: A Brief Report.
    J Pediatr Hematol Oncol. 2024 Jun 4. doi: 10.1097/MPH.0000000000002893.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

16. GERA K, Cline C, Al-Mansour Z, Medvec A, et al
    A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia.
    Leuk Lymphoma. 2024 Jun 6:1-9. doi: 10.1080/10428194.2024.2361111.
    PubMed         Abstract available
    
    
17. SHOUSE G, Chen L, Siddiqi T, Muir A, et al
    A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
    Leuk Lymphoma. 2024 Jun 5:1-4. doi: 10.1080/10428194.2024.2361841.
    PubMed        
    
    
18. FREI CR, Ryan K, Obodozie-Ofoegbu GO, Moore AM, et al
    Shift in first-line therapies for United States Veterans Affairs (VA) patients with chronic lymphocytic leukemia (CLL).
    Leuk Lymphoma. 2024 Jun 4:1-4. doi: 10.1080/10428194.2024.2360526.
    PubMed        
    
    

    
    Leukemia

19. OSTERGAARD A, Fiocco M, de Groot-Kruseman H, Moorman AV, et al
    ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?
    Leukemia. 2024 Jun 6. doi: 10.1038/s41375-024-02287.
    PubMed         Abstract available
    
    
20. ZHANG MY, Othus M, McMillen K, Erba HP, et al
    Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203.
    Leukemia. 2024 Jun 3. doi: 10.1038/s41375-024-02288.
    PubMed         Abstract available
    
    
21. VAN DER VELDEN VHJ, Dombrink I, Alten J, Cazzaniga G, et al
    Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines.
    Leukemia. 2024;38:1315-1322.
    PubMed         Abstract available
    
    
22. SAYITOGLU EC, Luca BA, Boss AP, Thomas BC, et al
    AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML.
    Leukemia. 2024;38:1246-1255.
    PubMed         Abstract available
    
    
23. YANG M, Ma Z, Wang C, Agca MC, et al
    Cre recombinase promotes leukemogenesis in the presence of both homozygous and heterozygous FLT3-ITD.
    Leukemia. 2024;38:1437-1439.
    PubMed        
    
    
24. LU W, Lyu H, Xiao X, Bai X, et al
    Prophylactic donor-derived CD19 CAR-T cell infusion for preventing relapse in high-risk B-ALL after allogeneic hematopoietic stem cell transplantation.
    Leukemia. 2024;38:1419-1422.
    PubMed        
    
    
25. VAN SPRONSEN MF, Van Gassen S, Duetz C, Westers TM, et al
    Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cells.
    Leukemia. 2024;38:1365-1377.
    PubMed         Abstract available
    
    
26. PERZOLLI A, Koedijk JB, Zwaan CM, Heidenreich O, et al
    Targeting the innate immune system in pediatric and adult AML.
    Leukemia. 2024;38:1191-1201.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.